Medical Journals

Expression of T-cadherin in Tumor Cells Influences Invasive Potential of Human Hepatocellular Carcinoma.

Authors:
  • Riou Philippe
  • Saffroy Raphael
  • Chenailler Catherine
  • Franc Brigitte
  • Gentile Carla
  • Rubinstein Eric
  • Resink Therese
  • Debuire Brigitte
  • Piatier-Tonneau Dominique
  • Lemoine Antoinette

From: Inserm U602, Université Paris XI, Villejuif, France.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

  • Publish Date: Nov 2006
  • ISSN: 1530-6860
  • Volume: 20
  • Issue: 13
  • Pages: 2291-301
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Riou Philippe, Saffroy Raphael, Chenailler Catherine, et al. Expression of T-cadherin in Tumor Cells Influences Invasive Potential of Human Hepatocellular Carcinoma.. FASEB J. Nov 2006;20:2291-301

Abstract

Overexpression of T-cadherin (T-cad) transcripts occurs in approximately 50% of human hepatocellular carcinomas (HCCs). To elucidate T-cad functions in HCC, we examined T-cad protein expression in normal and tumoral human livers and hepatoma cell lines and investigated its influence on invasive potential of HCC using RNA interference silencing of T-cad expression in Mahlavu cells. Whereas T-cad expression was restricted to endothelial cells (EC) from large blood vessels in normal livers, it was up-regulated in sinusoidal EC from 8/15 invasive HCCs. Importantly, in three of them (38%) T-cad was detected in tumor cells within regions in which E-cadherin expression was absent. Among six hepatoma cell lines, only Mahlavu expressed T-cad but not E-cadherin. T-cad exhibited a globally punctuate distribution in quiescent Mahlavu and additionally it concentrated at the leading edge of migrating cells. Matrigel invasion assay revealed that Mahlavu possess a high invasive potential that was significantly inhibited by T-cad silencing. Wound healing and random motility assays demonstrated that inhibition of T-cad expression in Mahlavu significantly reduced their motility. We propose that T-cad expression in tumor cells might occur by cadherin-switching during epithelial-mesenchymal transition and may represent an additional mechanism contributing to HCC metastasis.

Mesh Headings (Keywords): Animals, Cadherins, Carcinoma, Hepatocellular, Cell Culture Techniques, Cell Division, Cell Line, Tumor, Cell Movement, DNA Primers, Endothelial Cells, Fibroblasts, Hepatocytes, Humans, Liver, Liver Neoplasms, Neoplasm Invasiveness, RNA, Small Interfering, Rabbits, Transcription, Genetic, Transfection, Wound Healing


Check for Full Text / PubMed Unique Identifier (PMID): 17077306


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.